Genetic pattern that predicts leukemia relapse discovered

May 11, 2010

A genetic pattern that predicts the likelihood of relapse in patients with one of the most aggressive forms of childhood leukemia has been discovered. Researchers publishing in the open access journal Molecular Cancer have identified a consistent pattern in five genes that has the potential to enable doctors to identify which patients would benefit from more aggressive treatment when first diagnosed with T-cell acute lymphoblastic leukemia (T-ALL).

Co-author Dr Alex Beesley of Perth's Telethon Institute for Child Health Research said "While up to 80% of children with T-ALL achieve complete remission, there are around 20% who relapse and whose prognosis can be very poor," Dr Beesley said. "In this study, we found a consistent pattern in the expression of five genes in patients that relapse. Importantly, this pattern was found to hold true across multiple patient cohorts, the first time that such a robust gene signature of this kind has been found for T-ALL. This gene signature would enable patients with T-ALL to be classified according to risk at the time of diagnosis."

Dr Beesley said the discovery had significant potential to improve outcomes for patients at high risk of relapse. "Patients identified using these markers could potentially be treated with more aggressive therapies from the outset to give them the best hope of achieving complete remission."

The research team analyzed bone marrow samples from children treated under the international Children's Oncology Group (COG) protocols.

They used gene-profiling (microarray) technology to model a five-gene classifier that accurately predicted clinical outcome in a cohort of 50 T-ALL patients. The five-gene classifier was further tested against three independent cohorts of T-ALL patients, using two different techniques (either quantitative RT-PCR or microarray ), and could predict patients with significantly adverse clinical outcome in each.

Dr Beesley said the study also provided clues to the biological mechanisms leading to relapse in T-ALL, which could ultimately identify potential targets for new therapies to the disease.

T-ALL affects approximately 15% of newly diagnosed pediatric leukemia patients. The prognostic potential of the gene markers identified from this research will now be investigated as part of a large international Children's Oncology Group study of T-ALL patients undergoing the latest therapy.

Explore further: New study helps to explain why breast cancer often spreads to the lung

More information: Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
Amanda L Cleaver, Alex H Beesley, Martin J Firth, Nina C Sturges, Rebecca A O'Leary, Stephen P Hunger, David L Baker and Ursula R Kees
Molecular Cancer (in press), www.molecular-cancer.com/imedia/1672642652330984_article.pdf?random=960475

add to favorites email to friend print save as pdf

Related Stories

Gene abnormality found to predict childhood leukemia relapse

Jan 07, 2009

Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how ...

Gene mutation improves leukemia drug's effect

Jun 17, 2008

Gene mutations that make cells cancerous can sometimes also make them more sensitive to chemotherapy. A new study led by cancer researchers at Ohio State University shows that a mutation present in some cases of acute leukemia ...

Molecular change may reveal risk of leukemia relapse

Apr 30, 2008

Researchers may have discovered a better way to distinguish acute leukemia patients who require aggressive treatment to prevent recurrence from those who need only standard therapy for cure. The study is published in the ...

Recommended for you

New breast cancer imaging method promising

3 hours ago

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Palliation is rarely a topic in studies on advanced cancer

3 hours ago

End-of-life aspects, the corresponding terminology, and the relevance of palliation in advanced cancer are often not considered in publications on randomized controlled trials (RCTs). This is the result of an analysis by ...

Breast cancer replicates brain development process

3 hours ago

New research led by a scientist at the University of York reveals that a process that forms a key element in the development of the nervous system may also play a pivotal role in the spread of breast cancer.

User comments : 0

More news stories

Team reprograms blood cells into blood stem cells in mice

Researchers at Boston Children's Hospital have reprogrammed mature blood cells from mice into blood-forming hematopoietic stem cells (HSCs), using a cocktail of eight genetic switches called transcription factors. The reprogrammed ...

Engineered E. coli produces high levels of D-ribose

D-ribose is a commercially important sugar used as a sweetener, a nutritional supplement, and as a starting compound for synthesizing riboflavin and several antiviral drugs. Genetic engineering of Escherichia co ...